Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.
Cholesterol
Cholesterol HDL
Cholesterol LDL
Latent Markov model
Prediabetes
Triglycerides
Type 2 diabetes
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
23 Aug 2020
23 Aug 2020
Historique:
received:
08
06
2020
accepted:
12
08
2020
entrez:
25
8
2020
pubmed:
25
8
2020
medline:
27
7
2021
Statut:
epublish
Résumé
Lipid abnormality pervasively is associated with the risk of type 2 diabetes mellitus. To the best of our knowledge, there is no study that has examined the longitudinal changes in a wide range of serum lipid profiles in prediabetic subjects in association with the risk of developing type 2 diabetes mellitus in the future. This study aimed to identify the patterns of changes in lipid profiles over time in prediabetic patients and to classify these subjects in order to highlight which patients are at high risk for future diabetes. This prospective 16-year (2003-2019) cohort study was conducted among 1228 prediabetic subjects. The study subjects were followed, and the changes in their lipid profiles, including triglycerides, cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol, were evaluated. The latent Markov model was used for data analysis. The mean (standard deviation) age of subjects was 44.0 (6.8) years, and 73.6% of them were female. The latent Markov model identified two latent states of subjects in terms of changes in lipid profiles: a low tendency to progress diabetes / high tendency to progress diabetes (74, 26%). The latent Markov model showed that the transition probability from a "low tendency to progress diabetic" state to a "high tendency to progress diabetic" state was lower than the transition probability from "high tendency to progress diabetic" state to "low tendency to progress diabetic" state. The present study showed that more than half of the first-degree relatives of T2DM had approximately normal lipid profiles and that these patients are more inclined to transition from a higher- to a lower-tendency diabetic state. These findings confirm the value of regular screening of first-degree relatives of T2DM. Moreover, preventive intervention strategies are recommended to reduce their risk of developing T2DM.
Sections du résumé
BACKGROUND
BACKGROUND
Lipid abnormality pervasively is associated with the risk of type 2 diabetes mellitus. To the best of our knowledge, there is no study that has examined the longitudinal changes in a wide range of serum lipid profiles in prediabetic subjects in association with the risk of developing type 2 diabetes mellitus in the future. This study aimed to identify the patterns of changes in lipid profiles over time in prediabetic patients and to classify these subjects in order to highlight which patients are at high risk for future diabetes.
METHODS
METHODS
This prospective 16-year (2003-2019) cohort study was conducted among 1228 prediabetic subjects. The study subjects were followed, and the changes in their lipid profiles, including triglycerides, cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol, were evaluated. The latent Markov model was used for data analysis.
RESULTS
RESULTS
The mean (standard deviation) age of subjects was 44.0 (6.8) years, and 73.6% of them were female. The latent Markov model identified two latent states of subjects in terms of changes in lipid profiles: a low tendency to progress diabetes / high tendency to progress diabetes (74, 26%). The latent Markov model showed that the transition probability from a "low tendency to progress diabetic" state to a "high tendency to progress diabetic" state was lower than the transition probability from "high tendency to progress diabetic" state to "low tendency to progress diabetic" state.
CONCLUSIONS
CONCLUSIONS
The present study showed that more than half of the first-degree relatives of T2DM had approximately normal lipid profiles and that these patients are more inclined to transition from a higher- to a lower-tendency diabetic state. These findings confirm the value of regular screening of first-degree relatives of T2DM. Moreover, preventive intervention strategies are recommended to reduce their risk of developing T2DM.
Identifiants
pubmed: 32829710
doi: 10.1186/s12944-020-01371-y
pii: 10.1186/s12944-020-01371-y
pmc: PMC7444073
doi:
Substances chimiques
Lipoproteins, HDL
0
Triglycerides
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
193Subventions
Organisme : Isfahan University of Medical Sciences
ID : IR.MUI.MED.REC.1398.532
Références
Prim Care Diabetes. 2015 Feb;9(1):60-7
pubmed: 24810146
Struct Equ Modeling. 2013 Oct 1;20(4):
pubmed: 24302849
Diabetes Care. 2011 Jan;34 Suppl 1:S4-10
pubmed: 21193627
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460
Curr Cardiol Rep. 2014 Aug;16(8):512
pubmed: 24950673
Nat Rev Endocrinol. 2011 Nov 08;8(4):228-36
pubmed: 22064493
Diabetes Care. 2020 Jan;43(Suppl 1):S193-S202
pubmed: 31862758
Rev Diabet Stud. 2016 Summer-Fall;13(2-3):187-196
pubmed: 28012282
Asian J Sports Med. 2011 Jun;2(2):106-16
pubmed: 22375226
J Clin Lipidol. 2016 Jan-Feb;10(1):150-60
pubmed: 26892132
Circulation. 2000 Mar 7;101(9):975-80
pubmed: 10704163
Am Heart J. 1985 Nov;110(5):1100-7
pubmed: 4061265
Diabetes Care. 1998 Sep;21(9):1414-31
pubmed: 9727886
Diabetes Care. 1999 Mar;22(3):399-402
pubmed: 10097917
Med J Aust. 2003 Oct 6;179(7):379-83
pubmed: 14503906
Diabet Med. 2007 Feb;24(2):200-7
pubmed: 17257284
Rev Diabet Stud. 2007 Fall;4(3):169-76
pubmed: 18084674
PLoS One. 2016 Apr 26;11(4):e0154345
pubmed: 27115999
Metabolism. 2014 Dec;63(12):1469-79
pubmed: 25242435
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Diabetes Care. 1998 Oct;21(10):1686-90
pubmed: 9773731
Diabetes Metab Syndr Obes. 2019 Jul 15;12:1123-1139
pubmed: 31410041
Diabetes Res Clin Pract. 2009 Jan;83(1):18-25
pubmed: 19091437
PLoS One. 2018 Aug 16;13(8):e0200775
pubmed: 30114196
Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):150-9
pubmed: 19229235
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Int J Environ Res Public Health. 2018 Sep 06;15(9):
pubmed: 30200612
J Diabetes Investig. 2014 Sep;5(5):501-6
pubmed: 25411616
Diabetes Metab J. 2012 Dec;36(6):422-32
pubmed: 23275936
Oman Med J. 2012 Jul;27(4):269-73
pubmed: 23071876